George R Painter (George Painter)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

High Fat Diet Induced

Pluripotent Stem Cells

Respiratory Syncytial Virus

Top Venues

Science (New York, N.Y.)

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Sourimant, Carolin M Lieber, Megha Aggarwal, Robert M Cox, Josef D Wolf, Jeong-Joong Yoon, Mart Toots, Chengjin Ye, Zachary M Sticher, Alexander A Kolykhalov, Luis Martinez-Sobrido, Gregory R Bluemling, Michael G Natchus, George R Painter, Richard K Plemper
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication. Science (New York, N.Y.) (2021)
Timothy P Sheahan, Amy C Sims, Shuntai Zhou, Rachel L Graham, Andrea J Pruijssers, Maria L Agostini, Sarah R Leist, Alexandra Schaefer, Kenneth H Dinnon Iii, Laura J Stevens, James D Chappell, Xiaotao Lu, Tia M Hughes, Amelia S George, Collin S Hill, Stephanie A Montgomery, Ariane J Brown, Gregory R Bluemling, Michael G Natchus, Manohar Saindane, Alexander A Kolykhalov, George R Painter, Jennifer L Harcourt, Azaibi Tamin, Natalie J Thornburg, Ronald Swanstrom, Mark R Denison, Ralph S Baric
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science translational medicine 12 (541) (2020)